Abstract
We assessed mpox virus prevalence in blood, pharyngeal, and rectal specimens among persons without characteristic rash presenting for JYNNEOS vaccine. Our data indicate that the utility of risk-based screening for mpox in persons without skin lesions or rash via pharyngeal swabs, rectal swabs, and/or blood is likely limited.
Author supplied keywords
Cite
CITATION STYLE
Ogale, Y. P., Baird, N., Townsend, M. B., Berry, I., Griffin, I., Lee, M., … Waltenburg, M. A. (2023). Evidence of Mpox Virus Infection among Persons Without Characteristic Lesions or Rash Presenting for First Dose of JYNNEOS Vaccine-District of Columbia, August 2022. Clinical Infectious Diseases, 77(2), 298–302. https://doi.org/10.1093/cid/ciad145
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
